The current proposal requests continuing support for a multidisciplinary General Clinical Research Center involving research on both adults and children. The objective of the Clinical Research Center at the University of Michigan is to perform meritorious research in humans, which leads to an improved understanding of human biology, the prevention of disease, the elucidation of disease processes, or novel approaches to the diagnosis and management of diseases in humans. In addition, the Clinical Research Center aims to function as: (a) an institutional resource as a focal point for training in clinical research and (b) as a national and state resource to complement patient care by the discovery of new knowledge to assist and improve the diagnosis and management of patients. Our work to achieve these goals during the past six years includes a series of important advances and achievements which are already contributing to the improvement of health care. In addition, many trainees have been exposed to the Clinical Research Center environment. During the next five years we propose to continue to work towards our goal with over 160 separate clinical research protocols which involve studies ranging from physiological and biochemical studies of normal human function, studies of the molecular pathology and pathophysiology of human disease states, clinical trials to modify human disease states with both established and experimental forms of therapy, and pharmacokinetic studies to understand the metabolism and distribution of specific drugs. To support this activity requires an inpatient service, outpatient service, computing facility, Biostatistical Consulting Service, Core Laboratory with a new Human Cell Genetics Facility, Administrative Service, and a complex series of physical facilities and equipment. The investigators involved in the research include individuals from the Departments of Internal Medicine, Surgery, Pediatrics, Human Genetics, Pharmacology, Psychiatry, Physiology, Biological Chemistry, Neurology, Dermatology, Radiology, Physical Medicine and Rehabilitation, Radiation Therapy, Otorhinolaryngology, School of Public Health, School of Nursing, and College of Pharmacy. A substantial training program is proposed involving Clinical Associate Physicians, fellows, Internal Medicine residents, medical students, nursing students, dietetic students and dietitians. It is anticipated that the research proposed will bring advances in the understanding of normal human function and disease states in many fields. Continuing support of the Clinical Research Center will provide a stable focus for clinical research at the University of Michigan.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000042-33
Application #
3089302
Study Section
General Clinical Research Centers Committee (CLR)
Project Start
1977-12-01
Project End
1995-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
33
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419
Spengler, Erin K; Kleiner, David E; Fontana, Robert J (2017) Vemurafenib-induced granulomatous hepatitis. Hepatology 65:745-748
Heidemann, Lauren; Law, James; Fontana, Robert J (2017) A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury. Dig Dis Sci 62:615-625
As-Sanie, Sawsan; Kim, Jieun; Schmidt-Wilcke, Tobias et al. (2016) Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain. J Pain 17:1-13
Hertz, Daniel L; Henry, N Lynn; Kidwell, Kelley M et al. (2016) ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors. Physiol Genomics 48:688-98
Mehta, Rupal; Cai, Xuan; Lee, Jungwha et al. (2016) Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol 1:548-56

Showing the most recent 10 out of 1380 publications